M. P. Moffat

727 total citations
17 papers, 607 citations indexed

About

M. P. Moffat is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, M. P. Moffat has authored 17 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in M. P. Moffat's work include Cardiac electrophysiology and arrhythmias (10 papers), Cardiac Ischemia and Reperfusion (9 papers) and Ion channel regulation and function (7 papers). M. P. Moffat is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Cardiac Ischemia and Reperfusion (9 papers) and Ion channel regulation and function (7 papers). M. P. Moffat collaborates with scholars based in Canada and Germany. M. P. Moffat's co-authors include Morris Karmazyn, Gregory R. Ferrier, Anton Lukas, Njanoor Narayanan, Christopher A. Ward, John R. Bend, Thomas S. Mock, Jianmin Duan, Morris Karmazyn and Michael J. Daly and has published in prestigious journals such as Circulation Research, Journal of Pharmacology and Experimental Therapeutics and Cardiovascular Research.

In The Last Decade

M. P. Moffat

17 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. P. Moffat Canada 11 352 292 237 99 81 17 607
István Leprán Hungary 20 548 1.6× 370 1.3× 287 1.2× 123 1.2× 55 0.7× 52 964
A. Van de Water Belgium 13 651 1.8× 386 1.3× 105 0.4× 112 1.1× 54 0.7× 24 959
Antonella Boraso Italy 11 233 0.7× 217 0.7× 119 0.5× 97 1.0× 25 0.3× 24 539
J. Salmon United Kingdom 8 132 0.4× 141 0.5× 251 1.1× 124 1.3× 49 0.6× 13 678
R Bolli United States 6 222 0.6× 158 0.5× 315 1.3× 143 1.4× 70 0.9× 8 700
Harjot K. Saini Canada 20 449 1.3× 379 1.3× 281 1.2× 132 1.3× 26 0.3× 30 944
Hiroko Uemura Japan 11 265 0.8× 297 1.0× 209 0.9× 70 0.7× 22 0.3× 25 558
D. J. Hearse United Kingdom 7 228 0.6× 214 0.7× 275 1.2× 70 0.7× 26 0.3× 9 601
Hiroko Hashizume Japan 13 203 0.6× 249 0.9× 241 1.0× 56 0.6× 25 0.3× 41 558
Kenichi Arimura Japan 6 321 0.9× 314 1.1× 176 0.7× 219 2.2× 31 0.4× 8 707

Countries citing papers authored by M. P. Moffat

Since Specialization
Citations

This map shows the geographic impact of M. P. Moffat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. P. Moffat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. P. Moffat more than expected).

Fields of papers citing papers by M. P. Moffat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. P. Moffat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. P. Moffat. The network helps show where M. P. Moffat may publish in the future.

Co-authorship network of co-authors of M. P. Moffat

This figure shows the co-authorship network connecting the top 25 collaborators of M. P. Moffat. A scholar is included among the top collaborators of M. P. Moffat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. P. Moffat. M. P. Moffat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ward, Christopher A., M. P. Moffat, & Morris Karmazyn. (1996). Signal transduction mechanisms in the ischemic and reperfused myocardium. Birkhäuser Basel eBooks. 76. 191–207. 5 indexed citations
2.
Su, Na, Jianmin Duan, M. P. Moffat, & Njanoor Narayanan. (1995). Age-related changes in electrophysiological responses to muscarinic receptor stimulation in rat myocardium. Canadian Journal of Physiology and Pharmacology. 73(10). 1430–1436. 9 indexed citations
3.
4.
Karmazyn, Morris & M. P. Moffat. (1993). Role of Na+/H+ exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovascular Research. 27(6). 915–924. 171 indexed citations
5.
Moffat, M. P., et al.. (1993). Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes. American Journal of Physiology-Heart and Circulatory Physiology. 264(4). H1154–H1160. 59 indexed citations
7.
Moffat, M. P., et al.. (1991). Activated neutrophils depress myocardial function in the perfused rabbit heart.. PubMed. 7(7). 323–30. 14 indexed citations
8.
Duan, Jianmin & M. P. Moffat. (1990). Protective effects of phosphatidylcholine against mechanisms of ischemia and reperfusion-induced arrhythmias in isolated guinea pig ventricular tissues. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(3). 342–8. 5 indexed citations
9.
Karmazyn, Morris & M. P. Moffat. (1990). Positive inotropic effects of low concentrations of leukotrienes C4 and D4 in rat heart. American Journal of Physiology-Heart and Circulatory Physiology. 259(4). H1239–H1246. 10 indexed citations
10.
Moffat, M. P.. (1987). Concentration-dependent effects of prostacyclin on the response of the isolated guinea pig heart to ischemia and reperfusion: possible involvement of the slow inward current.. Journal of Pharmacology and Experimental Therapeutics. 242(1). 292–299. 22 indexed citations
11.
Moffat, M. P., Gregory R. Ferrier, & Morris Karmazyn. (1986). A possible role for endogenous prostaglandins in the electrophysiological effects of acetylstrophanthidin on isolated canine ventricular tissues.. Circulation Research. 58(4). 486–494. 7 indexed citations
12.
Karmazyn, Morris & M. P. Moffat. (1985). Toxic properties of arachidonic acid on normal, ischemic and reperfused hearts. Indirect evidence for free radical involvement. Prostaglandins Leukotrienes and Medicine. 17(2). 251–264. 21 indexed citations
13.
Moffat, M. P., Morris Karmazyn, & Gregory R. Ferrier. (1985). Prostaglandin involvement in hypersensitivity of ischemic hearts to arrhythmogenic influence of ouabain. American Journal of Physiology-Heart and Circulatory Physiology. 249(1). H57–H63. 4 indexed citations
14.
Ferrier, Gregory R., M. P. Moffat, & Anton Lukas. (1985). Possible mechanisms of ventricular arrhythmias elicited by ischemia followed by reperfusion. Studies on isolated canine ventricular tissues.. Circulation Research. 56(2). 184–194. 148 indexed citations
15.
Karmazyn, Morris & M. P. Moffat. (1984). Calcium-ionophore stimulated release of leukotriene C4-like immunoreactive material from cardiac tissue. Journal of Molecular and Cellular Cardiology. 16(11). 1071–1073. 24 indexed citations
16.
Karmazyn, Morris, et al.. (1982). A possible mechanism of inotropic action of prolactin on rat heart. American Journal of Physiology-Endocrinology and Metabolism. 243(6). E458–E463. 12 indexed citations
17.
Karmazyn, Morris, M. P. Moffat, Robert E. Beamish, & N. S. Dhalla. (1981). Comparative effects of acetylsalicylic acid (ASA) and sulfinpyrazone on isoproterenol-induced heart damage.. Journal of Pharmacology and Experimental Therapeutics. 218(3). 764–770. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026